Background illustration for clinical trials search

Lupus Nephritis Clinical Trials

Browse 30 lupus nephritis clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

for
Lupus Nephritis
Location: Columbus OH, Lawrenceville GA, Atlanta GA,
Sponsor: NephroNet, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07225387

Recruiting
Active & Responsive

Lupus Landmark Study: A Prospective Registry and Biorepository

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis,
Location: Boston MA, Worcester MA, Quebec, Manhasset NY,
Sponsor: Lupus Research Alliance

Sex: All

Age: 18 - 70+

Code: NCT05934149

Recruiting
Active & ResponsiveNew

A Phase IIa Study of ICG318 CAR-T in Refractory Systemic Lupus Erythematosus With or Without Lupus Nephritis

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)
Location: New Hyde Park NY
Sponsor: iCell Gene Therapeutics

Sex: All

Age: 16 - 70

Code: NCT07328581

Phase2, Recruiting
Active & Responsive

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Fayetteville NC, Miami FL, Cooper City FL,
Sponsor: Fate Therapeutics

Sex: All

Age: 12 - 70

Code: NCT07570862

Phase2, Recruiting

The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) Study

for
Lupus Nephritis
Location: New York NY, Hackensack NJ, Chapel Hill NC,
Sponsor: Children's Hospital Medical Center, Cincinnati

Sex: All

Age: 8 - 20

Code: NCT05538208

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Research Accelerated by You Lupus Registry

for
Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN),
Location: Washington D.C. DC
Sponsor: Lupus Foundation of America

Sex: All

Age: 0+

Code: NCT06927219

Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

for
SLE (Systemic Lupus), Lupus Erythematosus, Systemic,
Location: Boston MA, Chapel Hill NC, Chicago IL, New Orleans LA,
Sponsor: CRISPR Therapeutics

Sex: All

Age: 18 - 70

Code: NCT06925542

Phase1, Recruiting

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants

for
Lupus Nephritis
Location: Queens NY, Hackensack NJ, Montreal, Toronto, Atlanta GA,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 5 - 17

Code: NCT05039619

Phase2, Recruiting

Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)

for
Kidney Diseases, Kidney Failure, Chronic, Diabetic Nephropathy,
Location: New York NY
Sponsor: The Rogosin Institute

Sex: All

Age: 18+

Code: NCT01802034

Recruiting

A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)

for
Lupus Nephritis, Primary Membranous Nephropathy
Location: Worcester MA, New York NY, Summit NJ, Syracuse NY,
Sponsor: Nkarta, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06557265

Phase1, Phase2, Recruiting

Study to Assess Real-world Effectiveness of Belimumab for Treatment of Adults With LN

for
Lupus Nephritis
Location: Baltimore MD, Charlotte NC, Columbus OH, Hixson TN
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06527872

Recruiting

VIBRANT: VIB4920 for Active Lupus Nephritis

for
Lupus Nephritis
Location: Manhasset NY, New York NY, Philadelphia PA, Hershey PA,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18+

Code: NCT05201469

Phase2, Recruiting

Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

for
Autoimmune Disorders, Systemic Sclerosis,
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06434363

Phase1, Phase2, Recruiting

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

for
Lupus Nephritis
Location: Boston MA, East Setauket NY, Philadelphia PA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05268289

Phase2, Recruiting

CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus

for
SLE, Systemic Lupus Erythematosus (SLE), CAR T Cell, CART19,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 10 - 29

Code: NCT06839976

Phase1, Phase2, Recruiting

A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G

for
IgA Nephropathy, Lupus Nephritis (LN),
Location: Lawrenceville GA
Sponsor: Akebia Therapeutics

Sex: All

Age: 16+

Code: NCT06419205

Phase2, Recruiting

Phase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)

for
Lupus Nephritis
Location: Orchard Park NY
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT06711887

Phase3, Recruiting

Wellness & Workforce Solution for Lupus/Lupus Nephritis

for
Lupus Nephritis
Location: Atlanta GA
Sponsor: Morehouse School of Medicine

Sex: Female

Age: 18+

Code: NCT06217107

Recruiting

US Zamto-cel Autoimmune Diseases

for
Lupus Nephritis, Systemic Lupus Erythematosus,
Location: Milwaukee WI
Sponsor: Miltenyi Biomedicine GmbH

Sex: All

Age: 18+

Code: NCT06708845

Phase1, Recruiting

A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101

for
Refractory Lupus Nephritis, Myasthaenia Gravis,
Location: Denver CO
Sponsor: Kyverna Therapeutics

Sex: All

Age: 18+

Code: NCT07403188

Recruiting